Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diagnosing Ovarian Cancer

By HospiMedica staff writers
Posted on 31 Aug 2005
A new study has shown that many women diagnosed with ovarian cancer had complained of symptoms at least four months before their diagnosis but only about one quarter were given any diagnostic tests in a timely manner. More...


Ovarian cancer is considered a silent killer since it comes to the attention of a doctor only in its late stages, when prognosis is poor. Adding to this deadly pattern is the fact that it is a fast-growing tumor, often progressing from early to advanced disease in as little as a year. Lately, there has been increasing evidence that patients may exhibit symptoms many months before diagnosis and advanced disease occur, suggesting that earlier diagnosis is possible.

In the new study, women with ovarian cancer were found to be at least twice as likely to present to a doctor with abdominal swelling or pelvic pain as early as 12 months before diagnosis. As early as nine months before diagnosis, they were likely to complain of pelvic pain. About 40% had one or more doctor visits for symptoms between 36 and four months before diagnosis, but only 25% had diagnostic pelvic imaging or CA125 serum tests during that period. Most received abdominal imaging or diagnostic gastrointestinal studies, less likely to establish the correct diagnosis. In contrast, 54% of ovarian cancer patients received pelvic imaging or CA125 serum testing within three months before their ovarian cancer was diagnosed.

"Our findings suggest that ovarian cancer could be diagnosed earlier in some patients whose diagnosis is currently delayed by at least four months because physicians order abdominal imaging or perform gastrointestinal procedures before they order a test more likely to diagnose ovarian cancer, such as pelvic imaging and/or CA125,” concluded the authors of the study.

The study was conducted by Lloyd H. Smith, M.D., Ph.D., of the University of California at Davis School of Medicine (Sacramento, USA), and colleagues. They compared diagnosis codes and claims for diagnostic procedures among 1,985 elderly women with ovarian cancer, 6,024 elderly women with localized breast cancer, and 10,941 age-matched women without cancer. The results of the study were reported in the August 22, 2005, online issue of Cancer (Wiley InterScience).






Related Links:
U. of California Davis School of Medicine

New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.